Dupixent 200 MG/1.14 ML syring 1.14ML
Ended Awarded
- Contract number
- SPE2DB25FE6W7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $98,468
Award facts
- Contract value 100% obligated
- $98,467.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Dupixent 200 mg/1.14 mL syringes valued at $98,467.72. This is a firm fixed price, non-set-aside competitive award with an ultimate completion date of September 16, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive $999,999,999 pharmaceutical prime vendor agreement running through December 2026 that enables the contractor to supply a broad range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates capability across multiple therapeutic domains and product categories, with all reviewed awards being competitively awarded and utilizing firm fixed pricing structures. This specific delivery order for Dupixent, a specialty pharmaceutical used in the treatment of atopic dermatitis and other allergic conditions, reflects the contractor's role in supplying specialty medications as part of the broader military health support mission.
Quick answers
Who was awarded contract SPE2DB25FE6W7?
SPE2DB25FE6W7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FE6W7 worth?
The government has obligated $98,468 on SPE2DB25FE6W7.
Is contract SPE2DB25FE6W7 an order under another contract?
Yes. SPE2DB25FE6W7 is a delivery order under SPE2DB20D1100, an indefinite delivery contract.
Was contract SPE2DB25FE6W7 competed?
The extent of competition for SPE2DB25FE6W7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award